Summer Special - Limited Time 65% Discount Offer - Ends in 0d 00h 00m 00s - Coupon code: top65certs

Free AIGP Questions Attempt

Page: 3 / 10
Total 164 questions

Artificial Intelligence Governance Professional Questions and Answers

Question 9

CASE STUDY

Please use the following answer the next question:

A mid-size US healthcare network has decided to develop an Al solution to detect a type of cancer that is most likely arise in adults. Specifically, the healthcare network intends to create a recognition algorithm that will perform an initial review of all imaging and then route records a radiologist for secondary review pursuant Agreed-upon criteria (e.g., a confidence score below a threshold).

To date, the healthcare network has taken the following steps: defined its Al ethical principles: conducted discovery to identify the intended uses and success criteria for the system: established an Al governance committee; assembled a broad, crossfunctional team with clear roles and responsibilities; and created policies and procedures to document standards, workflows, timelines and risk thresholds during the project.

The healthcare network intends to retain a cloud provider to host the solution and a consulting firm to help develop the algorithm using the healthcare network's existing data and de-identified data that is licensed from a large US clinical research partner.

The most significant risk from combining the healthcare network’s existing data with the clinical research partner data is?

Options:

A.

Privacy risk.

B.

Security risk.

C.

Operational risk.

D.

Reputational risk.

Question 10

You are the chief privacy officer of a medical research company that would like to collect and use sensitive data about cancer patients, such as their names, addresses, race and ethnic origin, medical histories, insurance claims, pharmaceutical prescriptions, eating and drinking habits and physical activity.

The company will use this sensitive data to build an Al algorithm that will spot common attributes that will help predict if seemingly healthy people are more likely to get cancer. However, the company is unable to obtain consent from enough patients to sufficiently collect the minimum data to train its model.

Which of the following solutions would most efficiently balance privacy concerns with the lack of available data during the testing phase?

Options:

A.

Deploy the current model and recalibrate it over time with more data.

B.

Extend the model to multi-modal ingestion with text and images.

C.

Utilize synthetic data to offset the lack of patient data.

D.

Refocus the algorithm to patients without cancer.

Question 11

Which type of existing assessment could best be leveraged to create an Al impact assessment?

Options:

A.

A safety impact assessment.

B.

A privacy impact assessment.

C.

A security impact assessment.

D.

An environmental impact assessment.

Question 12

You are part of your organization’s ML engineering team and notice that the accuracy of a model that was recently deployed into production is deteriorating.

What is the best first step address this?

Options:

A.

Replace the model with a previous version.

B.

Conduct champion/challenger testing.

C.

Perform an audit of the model.

D.

Run red-teaming exercises.

Page: 3 / 10
Total 164 questions